Prototype ebola clinical trials, jmedicc

Ended Other Transaction Agreement Awarded Last action

Contract number
W911QY1990015
Awardee
Awarding agency
Obligated
$6,359,402

Award facts

Contract value 13% obligated
  • $6,379,401.88 Current, with exercised options
  • $48,482,241.10 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Westlake, MD 20817, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Prototype OTA clinical trials $0
Other Administrative Action P00008 · Ebola MCM development $0
Other Administrative Action P00007 · Prototype development of a avtx. $0
Funding Only Action P00006 · Funding action. $0
Other Administrative Action P00005 · No cost extension of clins 0001, 0002, 0011. $0
Funding Only Action P00004 · Incremental funding $2,000,000
Other Administrative Action P00003 · Clin no cost extension $0
Funding Only Action P00002 · Incremental funding action. $856,444
Funding Only Action P00001 · Incremental funding $200,000
Original award $3,302,958

About this award

Written by GovTribe AI ·

This is a $48,482,241.10 Other Transaction Agreement awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF) for PROTOTYPE EBOLA CLINICAL TRIALS, JMEDICC. The contract has a completion date of December 31, 2022 and was awarded on July 2, 2019. HJF is a non-profit organization that supports the U.S. Military Health System through research, education, and training. This contract does not have a set-aside designation. HJF has held other prime and subcontract awards with agencies like the Defense Health Agency, Uniformed Services University, and National Institutes of Health, delivering services in areas such as combat casualty care, traumatic brain injury, disease prevention, and military telehealth capabilities.

Quick answers

Who was awarded contract W911QY1990015?

W911QY1990015 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 2, 2019.

How much is contract W911QY1990015 worth?

The government has obligated $6,359,402 on W911QY1990015. Its current value, with exercised options, is $6,379,402. Its potential value, with all options, is $48,482,241.

Which agency awarded contract W911QY1990015?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY1990015, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY1990015 competed?

The extent of competition for W911QY1990015 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login